Immunopathogenesis of Emerging Infections Diseases in Humans

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:19 publications

Grant number: MC_U137881015

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2005
    2010
  • Known Financial Commitments (USD)

    $2,212,207.94
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Dr. X Xu
  • Research Location

    United Kingdom
  • Lead Research Institution

    MRC Human Immunology Unit
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Many viruses establish life-long infections in their natural host with few if any clinical manifestations. The relationship between virus and host is a dynamic process in which the virus has evolved the means to coexist by reducing its visibility, while the host immune system attempts to suppress and eliminate infection without damage to itself. Emerging infectious diseases pose a potential threat to public health such as human immunodeficiency virus (HIV), Severe Acute Respiratory Syndrome (SARS) virus and avian influenza. Our research focuses mainly on study of the host cellular immune responses to virus infections at the molecular, cellular and population levels. The aim is to gain a better understanding of the mechanisms of immunological damage (immunopathology) versus protection during the course of emerging pathogen infections in humans, and to apply this knowledge to the development of powerful therapies as well as effective vaccines.||Current work involves the following projects: 1) role of Nef gene in HIV-associated pathogenesis; 2) role of HGV (GBV-C) co-infection in HIV-1 pathogenesis; 3) functions of CD1 molecules and their role in virus infections; 4) immune responses to SARS coronavirus; 5) immune responses to influenza virus infection.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.

Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction.

NKT cells in HIV-1 infection.

Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein.

A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections.

T cell responses to whole SARS coronavirus in humans.

Lower cellular immune responses to influenza A (H3N2) in the elderly.